» Articles » PMID: 15834241

What's the Message? Interpretation of an Uninformative BRCA1/2 Test Result for Women at Risk of Familial Breast Cancer

Overview
Journal Genet Med
Publisher Elsevier
Specialty Genetics
Date 2005 Apr 19
PMID 15834241
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To test the "false-reassurance hypothesis," which suggests that women who receive an uninformative BRCA1/2 test result may incorrectly conclude that they no longer have an elevated risk, with possible harmful consequences for adherence to breast surveillance guidelines.

Methods: A prospective questionnaire design was used to compare 183 women with an uninformative BRCA test result (94 affected and 89 unaffected) with 41 proven BRCA mutation-carriers and 49 true negatives before and after BRCA1/2 test disclosure.

Results: After DNA-test disclosure, test applicants differed from each other with regard to their perception of the likelihood of carrying a deleterious gene (P < 0.0001). The BRCA mutation carriers reported the highest perceived likelihood and the true negatives reported the lowest. Compared to the predisclosure measures, women who received an uninformative DNA test result reported a lower perceived risk after disclosure (P < 0.0001), suggesting a relatively high level of reassurance because of the test result. However, after DNA-test disclosure, only 12 women concluded that the risk of carrying a mutation was nonexistent, and perceived likelihood was significantly associated with the pedigree-based risk assessment (P = 0.0001). Moreover, despite the significant decrease in perceived likelihood for uninformative women, intention to obtain mammograms did not change (P = 0.71); it remained at the same almost optimal level as for BRCA mutation carriers.

Conclusion: No support was found for the suggestion that the nature of uninformative test results is often misunderstood. Moreover, an uninformative test result did not affect the positive mammography intentions of both affected and unaffected women.

Citing Articles

Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes.

Makhnoon S, Chen M, Levin B, Ensinger M, Mattie K, Grana G Cancer. 2022; 128(20):3709-3717.

PMID: 35996941 PMC: 11160485. DOI: 10.1002/cncr.34429.


Heterogeneity in the psychosocial and behavioral responses associated with a diagnosis of suspected Lynch syndrome in women with endometrial cancer.

Jonnagadla S, Joseland S, Saya S, Den Elzen N, Isbister J, Winship I Hered Cancer Clin Pract. 2022; 20(1):27.

PMID: 35840994 PMC: 9284782. DOI: 10.1186/s13053-022-00233-1.


"Left in limbo": Exploring how patients with colorectal cancer interpret and respond to a suspected Lynch syndrome diagnosis.

Den Elzen N, Joseland S, Saya S, Jonnagadla S, Isbister J, Winship I Hered Cancer Clin Pract. 2021; 19(1):43.

PMID: 34656160 PMC: 8520179. DOI: 10.1186/s13053-021-00201-1.


Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.

Himes D, Gibbons D, Birmingham W, Beckstrand R, Gammon A, Kinney A J Genet Couns. 2019; 28(5):950-961.

PMID: 31199558 PMC: 7340114. DOI: 10.1002/jgc4.1147.


Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.

Albada A, van Dulmen S, Dijkstra H, Wieffer I, Witkamp A, Ausems M J Genet Couns. 2015; 25(2):279-89.

PMID: 26321750 PMC: 4799246. DOI: 10.1007/s10897-015-9869-x.